Download Free Medical Hemolytic anemias-Hemoglobinopathies PowerPoint Presentation

Hemolytic anemias-Hemoglobinopathies PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "Hemolytic anemias - Hemoglobinopathies”.

This medical PowerPoint presentation is about hemoglobinopathies, a type of intrinsic hemolytic anemia.

Hemolytic anemias are a group of disorders characterized by the premature destruction of red blood cells (RBCs), leading to a decreased lifespan of RBCs and subsequently, a decreased level of hemoglobin in the blood. Hemolytic anemias can be classified as either intrinsic or extrinsic, depending on the underlying cause.

Hemoglobinopathies are a type of intrinsic hemolytic anemia that are caused by genetic mutations affecting the structure or production of hemoglobin, the protein in RBCs that carries oxygen. Examples of hemoglobinopathies include sickle cell anemia, thalassemia, and hemoglobin C disease.

Sickle cell anemia is caused by a mutation in the beta-globin gene that results in the production of abnormal hemoglobin molecules. These abnormal hemoglobin molecules can cause RBCs to become rigid and sickle-shaped, leading to obstruction of blood vessels and tissue damage. Thalassemia is caused by mutations in the alpha- or beta-globin genes, which lead to decreased or absent production of one or both of these globins, resulting in the production of abnormal hemoglobin and decreased RBC lifespan. Hemoglobin C disease is caused by a mutation in the beta-globin gene, resulting in the production of abnormal hemoglobin molecules that can cause RBCs to become rigid and abnormally shaped.

Treatment for hemolytic anemias and hemoglobinopathies may include blood transfusions, medication, bone marrow transplantation, or gene therapy, depending on the severity of the condition and the underlying cause.

Tags : Hemolytic anemias, Hemoglobinopathies, Hematology, Hematology PowerPoint presentation

Published on : May 29, 2023 | Views : 903 | Downloads : 3

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Hemolytic anemias - Hemoglobinopathies Part 2
Slide 2-

Thalassemias Thalassemias are a heterogenous group of genetic disorders Individuals with homozygous forms are severely affected and die early in childhood without treatment Heterozygous individuals exhibit varying levels of severity The disorders are due to mutations that decrease the rate of synthesis of one of the two globin chains ( or ). The genetic defect may be the result of:
Slide 3-

Thalassemias A mutation in the noncoding introns of the gene resulting in inefficient RNA splicing to produce mRNA, and therefore, decreased mRNA production The partial or total deletion of a globin gene A mutation in the promoter leading to decreased expression A mutation at the termination site leading to production of longer, unstable mRNA A nonsense mutation Any of these defects lead to: An excess of the other normal globin chain A decrease in the normal amount of physiologic hemoglobin made Development of a hypochromic, microcytic anemia
Slide 4-

Thalassemias Beta () thalassemia The disease manifests itself when the switch from  to  chain synthesis occurs several months after birth There may be a compensatory increase in  and  chain synthesis resulting in increased levels of hgb F and A2. The genetic background of  thalassemia is heterogenous and may be roughly divided into two types: 0 in which there is complete absence of  chain production. This is common in the Mediterranean. + in which there is a partial block in  chain synthesis. At least three different mutant genes are involved: +1 – 10% of normal  chain synthesis occurs +2 – 50% of normal  chain synthesis occurs +3 - > 50% of normal  chain synthesis occurs
Slide 5-

Thalassemias The clinical expression of the different gene combinations (1 from mom and 1 from dad) are as follows: 0/0, +1/ +1, or 0/ +1,+2,or +3 = thalassemia major, the most severe form of the disease. Imbalanced synthesis leads to decreased total RBC hemoglobin production and a hypochromic, microcytic anemia. Excess  chains precipitate causing hemolysis of RBC precursors in the bone marrow leading to ineffective erythropoiesis In circulating RBCs,  chains may also precipitate leading to pitting in the spleen and decreased RBC survival via a chronic hemolytic process. The major cause of the severe anemia is the ineffective erythropoiesis.
Slide 6-

Thalassemias The severe, chronic anemia early in life leads to marked expansion of the marrow space and skeletal changes due to the increased erythropoiesis. Untreated individuals die early, usually of cardiac failure (due to overwork and hemochromatosis). Individuals may have massive splenomegaly leading to secondary leucopoenia and thrombocytopenia. This can lead to infections and bleeding problems. Lab findings include: - hypochromic, microcytic anemia - marked anisocytosis and poikilocytosis - schistocytes, ovalocytes, and target cells - basophilic stippling from  chain precipitation - increased reticulocytes and nucleated RBCs
Slide 7-

Thalassemias - serum iron and ferritin are normal to increased and there is increased saturation - chronic hemolysis leads to increased bilirubin and gallstones - hemoglobin electrophoresis shows increased hgb F, variable amounts of hgb A2, and no to very little A
Slide 8-

Thalassemia major
Slide 9-

Thalassemias Therapy – transfusions plus iron chelators to prevent hemochromatosis and tissue damage from iron overload; Gene therapy?  +2, or 3 homozygous = thalassemia intermedia Heterozygosity of 0, or + = thalassemia minor Mild hypochromic, microcytic anemia Patients are usually asymptomatic with symptoms occurring under stressful conditions such as pregnancy  thalassemia may also be found in combination with any of the hemoglobinopathies (S, C, or E) leading to a mild to severe anemia depending upon the particular combination.
Slide 10-

Thalassemia minor
Slide 11-

Thalassemias Alpha () thalassemia The disease is manifested immediately at birth There are normally four alpha chains, so there is a great variety in the severity of the disease. At birth there are excess  chains and later there are excess  chains. These form stable, nonfunctional tetramers that precipitate as the RBCs age leading to decreased RBC survival. The disease is usually due to deletions of the  gene and occasionally to a functionally abnormal  gene.
Slide 12-

Thalassemias The normal haploid genotype is /  If one gene is deleted, the haploid phenotype is  thal 2 If both genes are deleted, the haploid phenotype is  thal 1 Since one gets two genes from each parent, there are four types of  thalassemia: /  thal 2 = silent carrier /  thal 1, or  thal 2/  thal 2 =  thal trait with mild anemia  thal 1/  thal 2 = hemoglobin H disease (4 = hgb H) Hgb H has a higher affinity for O2 and precipitates in older cells. Anemia may be chronic to moderate to severe.
Slide 13-

Thalassemias  thal 1/  thal 1 = hydrops fetalis which is fatal with stillbirth or death within hours of birth. Hemoglobin Barts (4) forms and has such a high affinity for O2 that no O2 is delivered to the tissues. Hgs S/  thalassemia – symptomless to moderate anemia Delta/beta (/) thalassemia – both  and  chains are absent with no or little compensatory increase in  chain synthesis. This leads to 100% hgb F and mild hypochromic, microcytic anemia Hereditary persistence of hgb F – are a group of heterogenous disorders with the absence of  and  chain synthesis which is compensated for by an increase in  chain synthesis leading to 100% hgb F. Since hgb F has an increased affinity for O2, this results in polycythemia.
Slide 14-

Thalassemias Hemoglobin Constant Spring – formed by a combination of two structurally abnormal  chains (each elongated by 31 amino acids at the COOH end) and two normal  chains. The abnormal  chains are inefficiently synthesized resulting in an  thal 1 like phenotype (excess  chains) Homozygous individuals have mild hypochromic, microcytic anemia similar to a mild a  thalassemia. Hemoglobin Lepore – a normal  chain plus a - hybrid (N-terminal , and C-terminal ). There is ineffective synthesis of the hybrid chain leading to  chain excess and the same problems seen in  thalassemia.
Slide 15-

Thalassemias Homozygous individuals have a mild to severe hypochromic, microcytic anemia Heterozygous individuals are asymptomatic.
Slide 16-

ppt slide no 16 content not found